Abstract
Patients who require an orthopaedic implant after cancer treatment present four linked problems: a bone bed damaged by radiotherapy or chemotherapy, large reconstructions under high mechanical load, a high risk of infection, and hardware that degrades the imaging and radiotherapy planning on which oncologic follow-up depends. This narrative review examines how each problem alters implant performance and which design responses have clinical support. Radiotherapy roughly doubles dental implant failure, is associated with loosening, infection, and periprosthetic fracture after arthroplasty, and leads to non-union in most radiation-associated femoral fractures treated by internal fixation. Deep infection affects about one in ten tumour endoprostheses. Additively manufactured porous titanium and porous tantalum support bone ingrowth, but follow-up rarely exceeds five years, and their large surface area may favour bacterial colonisation. Silver, iodine, and antibiotic-loaded hydrogel coatings are associated with fewer infections in observational studies, with low certainty. Carbon-fibre-reinforced polyetheretherketone (PEEK) reduces imaging artefact and dose perturbation, and biodegradable magnesium avoids hardware removal, but neither has a proven advantage in oncologic reconstruction. Throughout, evidence is labelled by its source—oncologic, extrapolated, or preclinical—and the comparative studies still needed are specified.

This publication has 137 references indexed in Scilit: